CYLD and B-cell chronic lymphocytic leukemia: Ethacrynic acid (EA), a diuretic drug that is a particular antagonist of Wnt signaling, has been shown to specifically kill CLL cells by interfering with the binding of LEF1 to DNA and restoring CYLD expression [131].